Quantcast

Maryland State Wire

Monday, May 12, 2025

FDA conducted second lowest number of inspections on Drugs companies in Maryland during Q1

Webp qjor7q6aba3j2gn1lh89sh3yxtfn

DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website

DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website

In the first quarter of 2025, two Drugs companies received two FDA inspections in Maryland, according to the U.S. Food and Drug Administration (FDA).

This was the second lowest number of inspections per type of company made by the FDA in Maryland, equalling 10% of all inspections in the first quarter of 2025.

Of all the Maryland companies involved in the Drugs sector, Jubilant Cadista Pharmaceuticals, Inc. received the most citations from the FDA in the first quarter of 2025.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.

FDA Inspections in Maryland During Q1
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products51
Drug Quality Assurance2
Food Composition, Standards, Labeling and Econ33
Foodborne Biological Hazards55
Human Cellular, Tissue, and Gene Therapies1
Monitoring of Marketed Animal Drugs, Feed, and Devices1
Technical Assistance: Food and Cosmetics2

MORE NEWS